| GNAO1 |
GNAO1: Guanine nucleotide-binding protein G(o) subunit alpha 2 |
EDNRB |
EDNRB, ETRB: Endothelin B receptor precursor |
1.132 |
Evidence |
|
| AGT |
AGT, SERPINA8: Angiotensinogen precursor |
F11 |
F11: Coagulation factor XI precursor |
1.132 |
Evidence |
|
| GNAS |
GNAS, GNAS1, GSP: Guanine nucleotide-binding protein G(s) subunit alpha isoforms |
CCR5 |
CCR5: CCR5 receptor (Fragment) |
1.132 |
Evidence |
|
| STAT1 |
STAT1: Signal transducer and activator of transcription 1-alpha/beta |
TESK1 |
TESK1: Dual specificity testis-specific protein kinase 1 |
1.132 |
Evidence |
|
| F11 |
F11: Coagulation factor XI precursor |
SERPINA7 |
SERPINA7, TBG: Thyroxine-binding globulin precursor |
1.132 |
Evidence |
|
| BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
SLA2 |
SLA2, C20orf156, SLAP2: Src-like-adapter 2 |
1.132 |
Evidence |
|
| GNAZ |
GNAZ: Guanine nucleotide-binding protein G(z) subunit alpha |
PTAFR |
PTAFR, PAFR: Platelet-activating factor receptor |
1.132 |
Evidence |
|
| TXK |
TXK, PTK4: Tyrosine-protein kinase TXK |
LNK |
SH2B3, LNK: SH2B adapter protein 3 |
1.132 |
Evidence |
|
| FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
TXK |
TXK, PTK4: Tyrosine-protein kinase TXK |
1.132 |
Evidence |
|
| C3AR1 |
C3AR1, AZ3B, C3R1, HNFAG09: C3a anaphylatoxin chemotactic receptor |
GNAI2 |
Galphai2 protein |
1.132 |
Evidence |
|
| AZGP1 |
AZGP1, tcag7.638: Alpha-2-glycoprotein 1, zinc-binding |
HLA-DMB |
HLA-DMB, DMB, RING7: HLA class II histocompatibility antigen, DM beta chain prec |
1.132 |
Evidence |
|
| NCK2 |
NCK2: Cytoplasmic protein NCK2 |
ABL2 |
ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 |
1.132 |
Evidence |
|
| MAPK8 |
MAPK8, JNK1, PRKM8: Mitogen-activated protein kinase 8 |
PTEN |
PTEN, MMAC1, TEP1: Phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase and du |
1.132 |
Evidence |
|
| IL6R |
IL6R: Interleukin-6 receptor alpha chain precursor |
THPO |
THPO, MGDF: Thrombopoietin precursor |
1.132 |
Evidence |
|
| TNFSF13B |
TNFSF13B, BAFF, UNQ401/PRO738, BLYS, TALL1, TNFSF20, ZTNF4: Tumor necrosis facto |
TNFRSF10C |
TNFRSF10C, DCR1, UNQ321/PRO366, LIT, TRAILR3, TRID: Tumor necrosis factor recept |
1.132 |
Evidence |
|
| CASP1 |
CASP1, IL1BC, IL1BCE: Caspase-1 precursor |
PEA15 |
PEA15: Astrocytic phosphoprotein PEA-15 |
1.132 |
Evidence |
|
| PLAT |
PLAT: Tissue-type plasminogen activator precursor |
SERPINA6 |
SERPINA6, CBG: Corticosteroid-binding globulin precursor |
1.132 |
Evidence |
|
| CASP9 |
CASP9, MCH6: Caspase-9 precursor |
DAPK1 |
DAPK1, DAPK: Death-associated protein kinase 1 |
1.132 |
Evidence |
|
| HGF |
HGF, HPTA: Hepatocyte growth factor precursor |
SERPINA4 |
SERPINA4, KST, PI4: Kallistatin precursor |
1.132 |
Evidence |
|
| ANXA6 |
ANXA6, ANX6: Annexin A6 |
CRKL |
CRKL: Crk-like protein |
1.13 |
Evidence |
|
| EIF4A1 |
EIF4A1, DDX2A, EIF4A: Eukaryotic initiation factor 4A-I |
PPIA |
PPIA, CYPA: Peptidyl-prolyl cis-trans isomerase A |
1.13 |
Evidence |
|
| PABPC1 |
PABPC1, PAB1, PABP1, PABPC2: Polyadenylate-binding protein 1 |
RPL5 |
RPL5, MSTP030: 60S ribosomal protein L5 |
1.13 |
Evidence |
|
| NUP50 |
NUP50, NPAP60L, PRO1146: Nucleoporin 50 kDa |
NUP153 |
IPI00514528 |
1.13 |
Evidence |
|
| PSMA4 |
PSMA4, PSC9: Proteasome subunit alpha type-4 |
HDAC2 |
HDAC2: Histone deacetylase 2 |
1.13 |
Evidence |
|
| CAD |
CAD: CAD protein [Includes: Glutamine-dependent carbamoyl-phosphate synthase |
MCM6 |
MCM6: DNA replication licensing factor MCM6 |
1.13 |
Evidence |
|
- 
-